Johnson & Johnson Postpones COVID-19 Vaccine in Europe
They said that the company is aware of cases of blood clots after vaccination with the drug. Moreover, the company is considering these cases together with the European health authorities.
The US regulators also previously decided to prohibit the use of this vaccine against the coronavirus by the American company Johnson & Johnson due to blood clots in vaccinated. The Food and Drug Administration (FDA) announced that more than 6.8 million doses of the drug have been administered in the United States, with six cases of severe thrombosis in those vaccinated.
In April, The New York Times reported that employees of the American Johnson & Johnson plant in Baltimore made a mistake while developing a coronavirus vaccine - the mistake was made when mixing ingredients. This resulted in the loss of 15 million doses of the drug. Because of the incident, the FDA is conducting an inspection of the plant.